Literature DB >> 24305645

Bilateral bispectral index monitoring during and after electroconvulsive therapy compared with magnetic seizure therapy for treatment-resistant depression.

M Soehle1, S Kayser, R K Ellerkmann, T E Schlaepfer.   

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) is a highly effective and established treatment for depression. Magnetic seizure therapy (MST) has recently been developed and seems equally effective while associated with fewer side-effects. Both require general anaesthesia, which could be quantified using the bispectral index (BIS). We compared ECT and MST with respect to recovery times, left-sided BIS, and left-right differences in BIS.
METHODS: In this prospective, observational study, we enrolled 10 successive patients receiving ECT and 10 patients undergoing MST. Anaesthesia was performed with propofol and monitored with a bilateral BIS sensor. The seizure was elicited when the BIS was within a range from 50 to 60. The time to eye opening was measured and bilateral BIS were recorded for 10 min after seizure induction.
RESULTS: A comparable anaesthetic depth was observed in the ECT and MST groups at baseline [mean (standard deviation, sd) BIS values of 94.1 (4.1) and 95.5 (3.0), respectively] and before seizure induction [mean (sd) BIS values of 52.3 (9.6) and 55.2 (10.3), respectively]. Post-ictally, MST patients opened their eyes significantly earlier than ECT patients [3.0 (1.0) vs 6.7 (1.3) min, P<0.001]. They showed a significantly higher BIS at 2 min after seizure induction [69.2 (10.1) vs 50.9 (15.9), P=0.003], and this difference was still present at 10 min after seizure induction [BIS 81.5 (6.5) vs 68.0 (16.4), P<0.001]. Significant differences between the left and right BIS were observed in neither the ECT nor the MST group.
CONCLUSIONS: At a comparable anaesthetic depth, MST is superior to ECT in terms of post-ictal recovery, which is correctly reflected by higher post-ictal BIS values. Unilateral BIS monitoring is sufficient to monitor anaesthetic depth in ECT and MST patients. TRIAL REGISTRY NUMBER: NCT 01318018.

Entities:  

Keywords:  anaesthetics i.v.; consciousness monitors; depressive disorder; electroconvulsive therapy; propofol; treatment-resistant

Mesh:

Substances:

Year:  2013        PMID: 24305645     DOI: 10.1093/bja/aet410

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  Bispectral EEG (BSEEG) to assess arousal after electro-convulsive therapy (ECT).

Authors:  Kasra Zarei; Nicholas A Sparr; Nicholas T Trapp; Elena D Neuhaus; John W Cromwell; Aaron D Boes; Gen Shinozaki
Journal:  Psychiatry Res       Date:  2020-01-25       Impact factor: 3.222

Review 2.  An overview on clinical aspects in magnetic seizure therapy.

Authors:  Alice Engel; Sarah Kayser
Journal:  J Neural Transm (Vienna)       Date:  2016-06-23       Impact factor: 3.575

Review 3.  Update on Neuromodulation for Treatment-Resistant Depression.

Authors:  Bettina Bewernick; Thomas E Schlaepfer
Journal:  F1000Res       Date:  2015-12-02

4.  The bilateral bispectral and the composite variability indexes during anesthesia for unilateral surgical procedure.

Authors:  Pedro Lopes-Pimentel; Maylin Koo; Javier Bocos; Antoni Sabaté
Journal:  Saudi J Anaesth       Date:  2017 Jan-Mar

5.  Cognitive and Neurophysiological Recovery Following Electroconvulsive Therapy: A Study Protocol.

Authors:  Ben J A Palanca; Hannah R Maybrier; Angela M Mickle; Nuri B Farber; R Edward Hogan; Emma R Trammel; J Wylie Spencer; Donald D Bohnenkamp; Troy S Wildes; ShiNung Ching; Eric Lenze; Mathias Basner; Max B Kelz; Michael S Avidan
Journal:  Front Psychiatry       Date:  2018-05-14       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.